Estrogen-related receptor alpha triggers the proliferation and migration of human non-small cell lung cancer via interleukin-6

被引:20
|
作者
Zhang, Jing [1 ]
Guan, Xiangqian [2 ]
Liang, Naixin [3 ,4 ]
Li, Shanqing [3 ,4 ]
机构
[1] Hebei North Univ, Affiliated Hosp 1, Dept Oncol, Zhangjiakou, Peoples R China
[2] Univ Sci & Technol China, Lab Affiliated Hosp 1, Hefei, Anhui, Peoples R China
[3] Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Thorac Surg, Beijing 100730, Peoples R China
[4] Chinese Acad Med Sci, Beijing 100730, Peoples R China
关键词
ERR; IL-6; NF-B; NSCLC; EPITHELIAL-MESENCHYMAL TRANSITION; ERR-ALPHA; EXPRESSION; BETA; IL-6; AROMATASE; TUMORS; STAT3; WOMEN; LINES;
D O I
10.1002/cbf.3337
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human non-small cell lung cancer (NSCLC) is one of the leading causes of cancer deaths worldwide. Estrogenic signals have been suggested to be important for the growth and metastasis of NSCLC cells. Our present data showed that estrogen-related receptor alpha (ERR), while not ERR or ERR, was significantly elevated in NSCLC cell lines as compared with that in normal bronchial epithelial cell line BEAS-2B. The expression of ERR in clinical NSCLC tissues was significantly greater than that in their matched normal adjacent tissues. Over expression of ERR can trigger the proliferation, migration, and invasion of NSCLC cells, while si-ERR or ERR inhibitor showed opposite effects. ERR can increase the mRNA and protein expression of IL-6, while not IL-8, IL-10, IL-22, VEGF, TGF-, or TNF-, in NSCLC cells. Silence of IL-6 attenuated ERR induced proliferation and cell invasion. Furthermore, our data revealed the inhibition of NF-B, while not ERK1/2 or PI3K/Akt, abolished ERR induced production of IL-6. This might be due to that overexpression of ERR can increase the expression and nuclear translocation of p65 in NSCLC cells. Collectively, our data showed that activation of NF-B/IL-6 is involved in ERR induced migration and invasion of NSCLC cells. It suggested that ERR might be a potential target for NSCLC treatment.
引用
收藏
页码:255 / 262
页数:8
相关论文
共 50 条
  • [41] Targeting Aromatase and Estrogen Signaling in Human Non-Small Cell Lung Cancer
    Marquez-Garban, Diana C.
    Chen, Hsiao-Wang
    Goodglick, Lee
    Fishbein, Michael C.
    Pietras, Richard J.
    STEROID ENZYMES AND CANCER, 2009, 1155 : 194 - 205
  • [42] Interleukin-6 (IL-6) as a potential predictive marker and a desensitizer for immunotherapy response in non-small cell lung cancer
    Wang, Y.
    Liu, C.
    Yang, L.
    Xu, H.
    Sun, N.
    ANNALS OF ONCOLOGY, 2021, 32 : S1007 - S1008
  • [43] Hypoxia drives estrogen receptor β-mediated cell growth via transcription activation in non-small cell lung cancer
    Su, Qi
    Chen, Kun
    Ren, Jiayan
    Zhang, Yu
    Han, Xu
    Leong, Sze Wei
    Wang, Jingjing
    Wu, Qing
    Tu, Kaihui
    Sarwar, Ammar
    Zhang, Yanmin
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2024, 102 (12): : 1471 - 1484
  • [44] A polyphyllin mixture inhibits the proliferation and migration of non-small cell lung cancer cells
    Sun, Qi
    Sun, Zhenyu
    PANMINERVA MEDICA, 2022, 64 (03) : 410 - 411
  • [45] HHIP overexpression inhibits the proliferation, migration and invasion of non-small cell lung cancer
    Zhao, Jian-Guo
    Wang, Jian-Fang
    Feng, Jiang-Feng
    Jin, Xue-Ying
    Ye, Wan-Li
    PLOS ONE, 2019, 14 (11):
  • [46] Estrogen receptor-alpha isoforms are the main estrogen receptors expressed in non-small cell lung carcinoma
    Pelekanou, Vasiliki
    Anastasiou, Eleftheria
    Bakogeorgou, Efstathia
    Notas, George
    Kampa, Marilena
    Garcia-Milian, Rolando
    Lavredaki, Katerina
    Moustou, Eleni
    Chinari, Georgia
    Arapantoni, Petroula
    O'Grady, Anthony
    Georgoulias, Vassilios
    Tsapis, Andreas
    Stathopoulos, Efstathios N.
    Castanas, Elias
    STEROIDS, 2019, 142 : 65 - 76
  • [47] Cytoplasmic estrogen receptor β as a potential marker in human non-small cell lung carcinoma
    Verma, Mohit Kumar
    Miki, Yasuhiro
    Abe, Keiko
    Niikawa, Hiromichi
    Sasano, Hironobu
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 : S91 - S102
  • [48] Increased TNF-A and interleukin-6 in breath condensate, BAL and blood of patients with non-small cell lung cancer
    Di Gioia, G
    Carpagnano, GE
    Resta, O
    CHEST, 2004, 126 (04) : 916S - 916S
  • [49] Serum hepatocyte growth factor and interleukin-6 as prognostic markers for stage III non-small cell lung cancer
    Ujiie, Hideki
    Tomida, Mikio
    Akiyama, Hirohiko
    Okada, Daisuke
    Nakajima, Yuki
    Sakai, Hiroshi
    Takiguchi, Yuichi
    Tanzawa, Hideki
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [50] Highly concordant coexpression of aromatase and estrogen receptor β in non-small cell lung cancer
    Abe, Keiko
    Miki, Yasuhiro
    Ono, Katsuhiko
    Mori, Miki
    Kakinuma, Hideaki
    Kou, Yuki
    Kudo, Nobutaka
    Koguchi, Masashi
    Niikawa, Hiromichi
    Suzuki, Satoshi
    Evans, Dean B.
    Sugawara, Shunichi
    Suzuki, Takashi
    Sasano, Hironobu
    HUMAN PATHOLOGY, 2010, 41 (02) : 190 - 198